The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...

Non-active site mutations such as L50F are crucial for restoring the viral fitness of SARS-CoV-2 main protease. Here, the authors use full-length Mpro protein as substrate and demonstrate that ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines to send his nomination to the full chamber.

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.

A key Senate committee supports Robert F. Kennedy Jr., President Trump's pick to head the Department of Health and Human Services. The full Senate will vote on his nomination.

Similar to the Democratic senators who have come out forcefully against Kennedy, Cassidy, in an interview with Fox News ...

Merck & Co has lowered its full-year revenue and earnings estimates because of the impact of COVID-19 on its business, which is focused on products administered in hospitals. The company’s ...

MINNEAPOLIS (FOX 9) - A study done by the University of Minnesota (U of M) found that early adult deaths are on the rise in the U.S., with COVID-19 and drug overdoses being the main causes.

Merck MRK has decided to stop the phase III HYPERION study early. The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators ... In vaccines, Merck’s pneumococcal disease vaccine Capvaxive was recommended ...